Akebia Therapeutics (NASDAQ:AKBA – Get Free Report) and ProMIS Neurosciences (NASDAQ:PMN – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations. Institutional and Insider Ownership 33.9% of Akebia […]
Comparing Bullfrog AI (NASDAQ:BFRG) & ProMIS Neurosciences (NASDAQ:PMN) dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
ProMIS Neurosciences Publishes Study Highlighting Oligomer Selectivity and Benefit of Amyloid-Beta-Directed Antibodies tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
ProMIS Neurosciences, Inc. (NASDAQ:PMN – Get Free Report)’s stock price shot up 1.5% during mid-day trading on Friday . The company traded as high as $1.98 and last traded at $1.98. 1,032 shares were traded during trading, a decline of 97% from the average session volume of 37,766 shares. The stock had previously closed at […]
ProMIS Neurosciences Publishes in the Journal of Biological Chemistry on the Interaction Between Pathogenic Proteins as a Treatment Target for ALS tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.